Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
US
National Institutes of Health
grant
open
#grants-gov-PAR-25-069
Response due Jan 07, 2027 · 00:00 UTC
Re-run AI extraction
Auto-enrichment did not complete. Trigger it manually — 10–20 seconds.
